Sonnet BioTherapeutics Holdings, Inc. financial data

Symbol
SONN on Nasdaq
Location
100 Overlook Center, Suite 102, Princeton, NJ
Fiscal year end
September 30
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 91.9 % -34.5%
Debt-to-equity 1.26K % +598%
Return On Assets -342 % -141%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.75M shares +29.8%
Common Stock, Shares, Outstanding 3.33M shares -36.1%
Entity Public Float 46.2M USD +532%
Common Stock, Value, Issued 333 USD -36.2%
Weighted Average Number of Shares Outstanding, Basic 3.97M shares +530%
Weighted Average Number of Shares Outstanding, Diluted 3.97M shares +530%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1M USD +5269%
Research and Development Expense 7.4M USD +15.9%
General and Administrative Expense 7.66M USD +28.8%
Operating Income (Loss) -14.1M USD -14.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.78M USD -7.71%
Income Tax Expense (Benefit) 158K USD
Net Income (Loss) Attributable to Parent -13.6M USD -69.8%
Earnings Per Share, Basic -7 USD/shares +94.1%
Earnings Per Share, Diluted -7 USD/shares +94.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 149K USD -93.4%
Accounts Receivable, after Allowance for Credit Loss, Current 500K USD
Assets, Current 1.32M USD -74.3%
Property, Plant and Equipment, Net 12.9K USD -45.8%
Operating Lease, Right-of-Use Asset 64.6K USD -54.4%
Other Assets, Noncurrent 486K USD -0.43%
Assets 2.06M USD -64.5%
Accounts Payable, Current 3.75M USD +99.6%
Accrued Liabilities, Current 3.32M USD +3.47%
Liabilities, Current 5.1M USD +64.1%
Operating Lease, Liability, Noncurrent 23.6K USD -78.7%
Liabilities 5.1M USD +60.5%
Retained Earnings (Accumulated Deficit) -128M USD -11.8%
Stockholders' Equity Attributable to Parent -3.05M USD -216%
Liabilities and Equity 2.06M USD -64.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.91M USD +5.87%
Net Cash Provided by (Used in) Financing Activities 7.62M USD +98.6%
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 3.33M shares -36.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.71M USD +531%
Deferred Tax Assets, Valuation Allowance 36.5M USD -1.67%
Deferred Tax Assets, Gross 36.5M USD -1.73%
Operating Lease, Liability 131K USD -35.8%
Depreciation 3.21K USD 0%
Lessee, Operating Lease, Liability, to be Paid 144K USD -39.4%
Operating Lease, Liability, Current 68.8K USD -15.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 48.2K USD -49.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 95.5K USD +2%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.8K USD -61.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 48.2K USD -49.5%
Deferred Tax Assets, Operating Loss Carryforwards 26.8M USD -4.44%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares
Additional Paid in Capital 125M USD +6.74%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 39.5K USD -36.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares